Altium, IPC Education Foundation, and Arduino Announce Student Electronics Design Competition
Altium LLC, the leading printed circuit board (PCB) software company, is partnering with the IPC Education Foundation (IPCEF) and Arduino to launch the first student electronics design challenge to engage, educate, and enhance printed circuit board (PCB) design capabilities while developing STEM solutions to environmental challenges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005457/en/
Upverter Education, a division of Altium, the IPC Education Foundation, and Arduino are partnering to create the first student design competition to engage, educate, and enhance students’ proficiencies in PCB design, with a focus on solving some of the world’s most pressing environmental challenges. (Photo: Altium LLC)
The Innovation for Environmental Change 2021 International Student Design Competition (#PCBeTheChange) engages student teams to help address common environmental concerns using Altium’s educational tools with Arduino hardware.
Teams from high schools and colleges will be using Altium’s Upverter Modular PCB design software and the Arduino Portenta H7 to create a prototype design that will improve the environment in each team’s respective local area. The teams will be challenged to tackle one or more environmental concerns, such as air pollution, water quality and solar energy capture.
As Lotte Nørregaard Andersen, Head of Arduino Education, elaborates, "At Arduino, we believe that it is very crucial to empower scientists of the future to address common challenges of our time using technology. We’re delighted to partner with Altium LLC and the IPC Education Foundation in the Innovation for Environmental Change 2021 International Student Design Competition; this competition really aligns with our goal of creating the next generation of STEM solutions."
Participating teams can enter the design challenge while harnessing Altium’s Upverter Education training modules plus the Upverter Modular tool. Altium features multiple educational initiatives designed to support high school STEM teachers and students, along with programs to support college students and industry professionals.
“Students learning electronics design can get a comprehensive overview of how to design their own hardware with guided training in easy-to-understand modules. We’re honored to support the next generation of electronics designers by providing the curriculum and tools students need for the contest,” adds Rea Callender, Vice President of Upverter Education.
Winning teams will be eligible to win cash prizes for each category: high school and college: $1500 (1st prize), $750 (2nd prize) and $500 (3rd prize), free access to IPC APEX EXPO in San Diego, CA from January 25-27, 2022 as well as virtual access to AltiumLive 2022 CONNECT, co-located alongside the IPC APEX EXPO at the San Diego Convention Center. Designs will be featured on display at the IPC Design Booth; awards will be presented at the IPC APEX EXPO STEM Outreach Event.
Charlene Gunter, Senior Director of IPCEF shares, “We believe that opportunities and experiences like this will allow students togain awareness and access to the electronics manufacturing industry and in turn help them reach their career goals. This collaborative partnership with Altium, Upverter Education, and Arduino showcases our mutual goals of engaging and educating students in PCB design, and we look forward to seeing the creativity and solutions the teams will create.”
Open registration is available via Upverter Education for the design challenge beginning on Monday, August 16th and runs through Friday, October 1st; team designs must be received online by Friday, November 19th. Competition winners will be announced on Friday, December 17th, followed by virtual presentations for the first place, and runner-up entrants.
For more information, please contact Upverter.Education@altium.com.
Altium, LLC (ASX:ALU) is a global software company headquartered in San Diego, California, accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.
About Upverter Education
Upverter Education, launched by Altium in September 2020, is addressing an important societal need by empowering STEM educators teaching engineering, electronics design, and robotics with free essential tools and classroom resources. The program has been honored with multiple awards, including the EdTech Breakthrough Award, for Best Engineering Learning Solution and the Gold STEVIE® American Business Award, further validating Altium’s innovative approach to supporting STEM education.
About IPC Education Foundation (IPCEF)
The IPC Education Foundation creates awareness of the careers the electronics manufacturing industry has to offer students in high school and college by providing them with opportunities to access people, courses, and knowledge through key programs: 1) The IPC Student Chapter program provides scholarships, industry-standard education, industry connections, and access to hands-on competitions, especially with the support of industry experts and professionals; 2) IPC Video Subscription Libraries provide access to industry-relevant content to students in high school and college, and 3) a variety of engagement initiatives like in-person/virtual events, webinars, and classroom activities.
Arduino is the leading open-source hardware and software company in the world. Born to provide an easy-to-use platform for anyone making interactive projects, Arduino has reached a growing community and adapted to new needs and challenges, branching out into products for IoT, wearables, 3D printing, and embedded environments. As of today, the Arduino community included approximately 30 million active users.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)18.9.2021 15:34:00 CEST | Press release
Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one underlying medical condition (the obese, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents) with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. This marks the first time a monoclonal antibody treatment for COVID-19 has received a full approval to treat patients with COVID-19 from the Korean MFDS. In February, the Korean MFDS granted a Conditional Marketing Authorisation (CMA) for the emergency use of regdanvimab (CT-P59) and allowed the use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, high blood pressure) w
Ipsen: ESMO 2021: Cabometyx ® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 06:30:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021
Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 20:46:00 CEST | Press release
Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005495/en/ Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli
Prince William announces 15 Finalists for inaugural year of the £50 million Earthshot Prize17.9.2021 19:01:00 CEST | Press release
The Earthshot Prize announces today its first-ever shortlist of 15 Finalists, each with a chance of winning £1million to support their innovative environmental solutions to the greatest challenges facing the planet. Prince William said: "Over half a century ago, President Kennedy’s ‘Moonshot’ programme united millions of people around the goal of reaching the moon. Inspired by this, The Earthshot Prize aims to mobilise collective action around our unique ability to innovate, problem solve and repair our planet. “I am honoured to introduce the 15 innovators, leaders, and visionaries who are the first ever Finalists for The Earthshot Prize. They are working with the urgency required in this decisive decade for life on Earth and will inspire all of us with their optimism in our ability to rise to the greatest challenges in human history.” Launched by Prince William and The Royal Foundation in October 2020, The Earthshot Prize is the most prestigious global environment prize in history. Li
Wipro Announces Co-innovation Space with Google Cloud17.9.2021 15:32:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business transformation for customers. By combining the expertise and resources of Wipro FullStride Cloud Services and Google Cloud, this jointly developed innovation center will offer a unique combination of people, processes, and platforms that will collectively create a futuristic experience for customers globally. This state-of-the-art arena will showcase the talent, tools and best practices required to develop and deploy applications on Google Cloud. Jason Eichenholz, Senior Vice President, Global Head of Ecosystems & Partnerships, Wipro Limited said, “We are excited to strengthen our partnership with Google Clou
Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat17.9.2021 15:00:00 CEST | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced today that ReVamp, an upcoming multiplayer social deception game, will launch soon in select markets exclusively for Snapchat. The vampire-themed game will be the first social deception title on Snapchat, giving Snapchatters their first chance to sink their teeth into this popular genre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005012/en/ Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat (Graphic: Business Wire) ReVamp is a real-time multiplayer imposter game where players aim to reveal who the vampire player is among their group of friends while they renovate the rooms of an old mansion. In the game, human players must complete renovation tasks, such as demolition and building, to improve their chances of survival while identifying and defeating the vampire during the voting phase. Vampire players mu
BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia17.9.2021 14:00:00 CEST | Press release
BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have emerged as a promising treatment for WM, yet treatment discontinuation due to lack of response or side effects remains a concern,” said Prof. Christian Buske, Medical Director at the University Hospital Ulm, Germany, and a trial investigator of the ASPEN study. “The ASPEN trial demonstrated that BRUKINSA provided deep and durable responses and offered substantial improvements in safety and tolerability over standard therapy. Patients in Europe with WM may soon have a new treatment option that can offer improved outcomes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom